论文部分内容阅读
目的:探讨前列地尔配合疏血通在后循环缺血性眩晕治疗中的应用价值。方法:从本院2011年12月—2013年12月收治的后循环缺血性眩晕患者中随机选择100例进行研究,随机分为观察组(50例)和对照组(50例),分别给予常规治疗和前列地尔配合疏血通治疗。观察记录两组的血液黏滞性和治疗效果,并进行比较。结果:治疗前,两组的各项血液黏度指标比较差异均无统计学意义(均P>0.05);治疗后,较之治疗前,在血液黏度各项指标方面,两组均出现显著下降现象(均P<0.05);但在下降幅度方面,观察组要明显大于对照组(P<0.05)。治疗结束后,观察组的治疗有效的患者一共有47例,治疗总有效率为94.0%;对照组仅有37例,总有效率为74.0%。在治疗总有效率方面两组差异有统计学意义(P<0.05)。在不良反应发生率方面,两组均为2.0%(P>0.05)。结论:前列地尔配合疏血通治疗后循环缺血性眩晕可以有效改善患者的血液黏滞性和眩晕症状,且不良反应轻微,具有一定的应用价值。
Objective: To investigate the application value of alprostadil combined with Shuxuetong in the treatment of posterior circulation ischemic vertigo. Methods: 100 patients were randomly selected from patients with posterior circulation ischemic vertigo admitted from December 2011 to December 2013 in our hospital. The patients were randomly divided into observation group (50 cases) and control group (50 cases) Routine treatment and alprostadil with Shuxuetong treatment. Observed and recorded the two groups of blood viscosity and therapeutic effect, and compared. Results: Before treatment, there were no significant differences in the indexes of blood viscosity between the two groups (all P> 0.05). After treatment, both groups showed significant decrease in all indexes of blood viscosity compared with those before treatment (All P <0.05). However, in the decreasing range, the observation group was significantly larger than the control group (P <0.05). After treatment, the observation group of patients with effective treatment a total of 47 cases, the total effective rate was 94.0%; control group, only 37 cases, the total effective rate was 74.0%. The total effective rate in the treatment of two groups was statistically significant (P <0.05). In the incidence of adverse reactions, both groups were 2.0% (P> 0.05). Conclusion: Alprostadil combined with Shuxuetong after treatment of ischemic vertigo can effectively improve the patient’s blood viscosity and dizziness symptoms, and mild adverse reactions, has a certain value.